Invention Grant
- Patent Title: Monoclonal antibody to PD-L1
-
Application No.: US16605865Application Date: 2018-04-11
-
Publication No.: US11236167B2Publication Date: 2022-02-01
- Inventor: Andrei Borisovich Ulitin , Viktoriia Mikhailovna Ekimova , Ekaterina Vladimirovna Sofronova , Yulia Sergeevna Chernykh , Sergei Andreevich Ageev , Anna Konstantinovna Vladimirova , Aleksei Aleksandrovich Aleksandrov , Pavel Alekseevich Grebnev , Valery Vladimirovich Solovyev , Iakov Iurevich Ustiugov , Pavel Andreevich Iakovlev , Timofey Aleksandrovich Nemankin , Dmitry Valentinovich Morozov
- Applicant: JOINT STOCK COMPANY “BIOCAD”
- Applicant Address: RU St.Petersburg
- Assignee: JOINT STOCK COMPANY “BIOCAD”
- Current Assignee: JOINT STOCK COMPANY “BIOCAD”
- Current Assignee Address: RU St.Petersburg
- Agency: Anglehart et al.
- Priority: RURU2017113141 20170417
- International Application: PCT/RU2018/050039 WO 20180411
- International Announcement: WO2018/194496 WO 20181025
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06
Abstract:
The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
Public/Granted literature
- US20200369771A1 MONOCLONAL ANTIBODY TO PD-L1 Public/Granted day:2020-11-26
Information query
